Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg

By Epstein S.   Jeglitsch M.   McCloskey E.  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2951-2960

Informa Healthcare

Access to resources Recommend Favorite

Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis

By Sebba Anthony I.   Bonnick Sydney Lou   Kagan Risa   Thompson Desmond E.   Skalky Carol S.   Chen Erluo   de Papp Anne E.    

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 2031-2041

Informa Healthcare

Access to resources Recommend Favorite

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis

By Klausner Howard A.   Brown Patricia   Peterson Janet   Kaul Simrati   Khashab Mohammed   Fisher Alan C.   Kahn James B.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2637-2645

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of long‐term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction

By  

ANDROLOGIA (ELECTRONIC), Vol. 47, Iss. 1, 2015-02 ,pp. : 20-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Canakinumab for the Treatment of Children With Colchicine‐Resistant Familial Mediterranean Fever: A 6‐Month Open‐Label, Single‐Arm Pilot Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3241-3243

John Wiley & Sons Inc

Access to resources Recommend Favorite